Recent Advances in Osteoclast Biology

Overview

Journal Histochem Cell Biol

Publisher Springer

Specialties Biochemistry
Cell Biology

Date 2018 Feb 3

PMID 29392395

Citations 169

Authors

Takehito Ono

Tomoki Nakashima

Affiliations

Soon will be listed here.

Abstract

The bone is an essential organ for locomotion and protection of the body, as well as hematopoiesis and mineral homeostasis. In order to exert these functions throughout life, bone tissue undergoes a repeating cycle of osteoclastic bone resorption and osteoblastic bone formation. The osteoclast is a large, multinucleated cell that is differentiated from monocyte/macrophage lineage cells by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL). RANKL transduces its signal through the signaling receptor, RANK. RANKL/RANK signaling activates NFATc1, the master regulator of osteoclastogenesis, to induce osteoclastogenic gene expression. Many types of cells express RANKL to support osteoclastogenesis depending on the biological context and the dysregulation of RANKL signaling leads to bone diseases such as osteoporosis and osteopetrosis. This review outlines the findings on osteoclast and RANKL/RANK signaling that have accumulated to date.

Citing Articles

Role of endosomal RANKL-LGR4 signaling during osteoclast differentiation.

Kim B, Cho Y, Jang Y, Ko K, Lee C, Lim W J Mol Med (Berl). 2025; 103(3):339-354.

PMID: 39954074 DOI: 10.1007/s00109-025-02523-2.

Casticin Inhibits Osteoclastogenesis via NF-κB/BCL-2 Signaling Pathway.

Huang A, Gu Z, Jin J, Nie T J Microbiol Biotechnol. 2025; 35:e2409009.

PMID: 39947684 PMC: 11876008. DOI: 10.4014/jmb.2409.09009.

Pediatric Fracture Remodeling: From Wolff to Wnt.

Gamble J Cureus. 2025; 17(1):e78266.

PMID: 39897217 PMC: 11782688. DOI: 10.7759/cureus.78266.

NEDD4 family E3 ligases in osteoporosis: mechanisms and emerging potential therapeutic targets.

Wu H, Zuo J, Dai Y, Li H, Wang S J Orthop Surg Res. 2025; 20(1):92.

PMID: 39849530 PMC: 11761774. DOI: 10.1186/s13018-025-05517-5.

Drug delivery for age-related bone diseases: From therapeutic targets to common and emerging therapeutic strategies.

Bi J, Zeng J, Liu X, Mo C, Yao M, Zhang J Saudi Pharm J. 2024; 32(12):102209.

PMID: 39697472 PMC: 11653637. DOI: 10.1016/j.jsps.2024.102209.

References

Gelb B, Shi G, Chapman H, Desnick R . Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996; 273(5279):1236-8. DOI: 10.1126/science.273.5279.1236. View

Lamothe B, Lai Y, Xie M, Schneider M, Darnay B . TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol. 2012; 33(3):582-95. PMC: 3554219. DOI: 10.1128/MCB.01225-12. View

Joyce-Shaikh B, Bigler M, Chao C, Murphy E, Blumenschein W, Adamopoulos I . Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med. 2010; 207(3):579-89. PMC: 2839155. DOI: 10.1084/jem.20090516. View

Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H . Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000; 275(3):768-75. DOI: 10.1006/bbrc.2000.3379. View

Shoji-Matsunaga A, Ono T, Hayashi M, Takayanagi H, Moriyama K, Nakashima T . Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression. Sci Rep. 2017; 7(1):8753. PMC: 5562866. DOI: 10.1038/s41598-017-09326-7. View

Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H . The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 1989; 125(4):1805-13. DOI: 10.1210/endo-125-4-1805. View

Ahlberg P, Clack J, Luksevics E, Blom H, Zupins I . Ventastega curonica and the origin of tetrapod morphology. Nature. 2008; 453(7199):1199-204. DOI: 10.1038/nature06991. View

Wright H, McCarthy H, Middleton J, Marshall M . RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med. 2009; 2(1):56-64. PMC: 2684955. DOI: 10.1007/s12178-009-9046-7. View

Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T . Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. J Bone Miner Res. 2013; 28(12):2463-75. DOI: 10.1002/jbmr.1989. View

10.

. Eighth Bone Quality Seminar Proceedings 2013. Osteoporos Int. 2014; 25 Suppl 3:S465-501. DOI: 10.1007/s00198-014-2681-x. View

11.

Aliprantis A, Ueki Y, Sulyanto R, Park A, Sigrist K, Sharma S . NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008; 118(11):3775-89. PMC: 2564610. DOI: 10.1172/JCI35711. View

12.

Kornak U, Kasper D, Bosl M, Kaiser E, Schweizer M, Schulz A . Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001; 104(2):205-15. DOI: 10.1016/s0092-8674(01)00206-9. View

13.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

14.

Takegahara N, Takamatsu H, Toyofuku T, Tsujimura T, Okuno T, Yukawa K . Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol. 2006; 8(6):615-22. DOI: 10.1038/ncb1416. View

15.

Matsuo K, Galson D, Zhao C, Peng L, Laplace C, Wang K . Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004; 279(25):26475-80. DOI: 10.1074/jbc.M313973200. View

16.

Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K . RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004; 200(7):941-6. PMC: 2213286. DOI: 10.1084/jem.20040518. View

17.

Speziani C, Rivollier A, Gallois A, Coury F, Mazzorana M, Azocar O . Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol. 2007; 37(3):747-57. DOI: 10.1002/eji.200636534. View

18.

Negishi-Koga T, Gober H, Sumiya E, Komatsu N, Okamoto K, Sawa S . Immune complexes regulate bone metabolism through FcRγ signalling. Nat Commun. 2015; 6:6637. DOI: 10.1038/ncomms7637. View

19.

Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T . Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun. 1997; 234(1):137-42. DOI: 10.1006/bbrc.1997.6603. View

20.

Izawa T, Zou W, Chappel J, Ashley J, Feng X, Teitelbaum S . c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol. 2012; 32(14):2943-53. PMC: 3416198. DOI: 10.1128/MCB.00077-12. View